nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—CYP1A2—Leflunomide—rheumatoid arthritis	0.0712	0.199	CbGbCtD
Maprotiline—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0507	0.142	CbGbCtD
Maprotiline—ABCB1—Betamethasone—rheumatoid arthritis	0.033	0.0921	CbGbCtD
Maprotiline—ABCB1—Prednisolone—rheumatoid arthritis	0.0325	0.0909	CbGbCtD
Maprotiline—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0308	0.0861	CbGbCtD
Maprotiline—ABCB1—Prednisone—rheumatoid arthritis	0.0307	0.0858	CbGbCtD
Maprotiline—ABCB1—Cyclosporine—rheumatoid arthritis	0.0291	0.0813	CbGbCtD
Maprotiline—CYP2D6—Cyclosporine—rheumatoid arthritis	0.0275	0.0766	CbGbCtD
Maprotiline—ABCB1—Dexamethasone—rheumatoid arthritis	0.0192	0.0536	CbGbCtD
Maprotiline—CYP2D6—Dexamethasone—rheumatoid arthritis	0.0181	0.0505	CbGbCtD
Maprotiline—ABCB1—Methotrexate—rheumatoid arthritis	0.0154	0.043	CbGbCtD
Maprotiline—Desipramine—SLC22A4—rheumatoid arthritis	0.00057	0.476	CrCbGaD
Maprotiline—Imipramine—SLC22A4—rheumatoid arthritis	0.000484	0.404	CrCbGaD
Maprotiline—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.000369	0.000793	CcSEcCtD
Maprotiline—Fatigue—Cyclosporine—rheumatoid arthritis	0.000368	0.000792	CcSEcCtD
Maprotiline—Headache—Azathioprine—rheumatoid arthritis	0.000367	0.000789	CcSEcCtD
Maprotiline—Hyperhidrosis—Hydrocortisone—rheumatoid arthritis	0.000367	0.000789	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Methotrexate—rheumatoid arthritis	0.000367	0.000789	CcSEcCtD
Maprotiline—Dizziness—Leflunomide—rheumatoid arthritis	0.000366	0.000787	CcSEcCtD
Maprotiline—Constipation—Cyclosporine—rheumatoid arthritis	0.000365	0.000785	CcSEcCtD
Maprotiline—Dry mouth—Triamcinolone—rheumatoid arthritis	0.000365	0.000784	CcSEcCtD
Maprotiline—Stomatitis—Methotrexate—rheumatoid arthritis	0.000361	0.000776	CcSEcCtD
Maprotiline—Angiopathy—Prednisone—rheumatoid arthritis	0.000361	0.000775	CcSEcCtD
Maprotiline—Confusional state—Methylprednisolone—rheumatoid arthritis	0.00036	0.000773	CcSEcCtD
Maprotiline—Oedema—Triamcinolone—rheumatoid arthritis	0.000357	0.000768	CcSEcCtD
Maprotiline—Syncope—Betamethasone—rheumatoid arthritis	0.000356	0.000766	CcSEcCtD
Maprotiline—Syncope—Dexamethasone—rheumatoid arthritis	0.000356	0.000766	CcSEcCtD
Maprotiline—Arrhythmia—Prednisone—rheumatoid arthritis	0.000355	0.000764	CcSEcCtD
Maprotiline—Infection—Triamcinolone—rheumatoid arthritis	0.000355	0.000763	CcSEcCtD
Maprotiline—Hypotension—Hydrocortisone—rheumatoid arthritis	0.000355	0.000763	CcSEcCtD
Maprotiline—Infection—Methylprednisolone—rheumatoid arthritis	0.000354	0.000762	CcSEcCtD
Maprotiline—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.000352	0.000757	CcSEcCtD
Maprotiline—Vomiting—Leflunomide—rheumatoid arthritis	0.000352	0.000757	CcSEcCtD
Maprotiline—Shock—Triamcinolone—rheumatoid arthritis	0.000352	0.000756	CcSEcCtD
Maprotiline—Insomnia—Prednisolone—rheumatoid arthritis	0.000352	0.000756	CcSEcCtD
Maprotiline—Alopecia—Prednisone—rheumatoid arthritis	0.000351	0.000755	CcSEcCtD
Maprotiline—Shock—Methylprednisolone—rheumatoid arthritis	0.000351	0.000754	CcSEcCtD
Maprotiline—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	0.00035	0.000753	CcSEcCtD
Maprotiline—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.00035	0.000752	CcSEcCtD
Maprotiline—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	0.000349	0.000751	CcSEcCtD
Maprotiline—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000349	0.000751	CcSEcCtD
Maprotiline—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.000349	0.000751	CcSEcCtD
Maprotiline—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000349	0.00075	CcSEcCtD
Maprotiline—Rash—Leflunomide—rheumatoid arthritis	0.000349	0.00075	CcSEcCtD
Maprotiline—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000349	0.00075	CcSEcCtD
Maprotiline—Dermatitis—Leflunomide—rheumatoid arthritis	0.000349	0.00075	CcSEcCtD
Maprotiline—Nausea—Azathioprine—rheumatoid arthritis	0.000348	0.000748	CcSEcCtD
Maprotiline—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000348	0.000748	CcSEcCtD
Maprotiline—Headache—Leflunomide—rheumatoid arthritis	0.000347	0.000745	CcSEcCtD
Maprotiline—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000346	0.000745	CcSEcCtD
Maprotiline—Malnutrition—Prednisone—rheumatoid arthritis	0.000346	0.000744	CcSEcCtD
Maprotiline—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000346	0.000743	CcSEcCtD
Maprotiline—Agranulocytosis—Methotrexate—rheumatoid arthritis	0.000345	0.000743	CcSEcCtD
Maprotiline—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000345	0.000741	CcSEcCtD
Maprotiline—Convulsion—Betamethasone—rheumatoid arthritis	0.000344	0.00074	CcSEcCtD
Maprotiline—Convulsion—Dexamethasone—rheumatoid arthritis	0.000344	0.00074	CcSEcCtD
Maprotiline—Insomnia—Hydrocortisone—rheumatoid arthritis	0.000343	0.000738	CcSEcCtD
Maprotiline—Hypertension—Dexamethasone—rheumatoid arthritis	0.000343	0.000738	CcSEcCtD
Maprotiline—Hypertension—Betamethasone—rheumatoid arthritis	0.000343	0.000738	CcSEcCtD
Maprotiline—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000341	0.000733	CcSEcCtD
Maprotiline—Urticaria—Cyclosporine—rheumatoid arthritis	0.000339	0.000729	CcSEcCtD
Maprotiline—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.000338	0.000726	CcSEcCtD
Maprotiline—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.000338	0.000726	CcSEcCtD
Maprotiline—Anxiety—Dexamethasone—rheumatoid arthritis	0.000337	0.000725	CcSEcCtD
Maprotiline—Anxiety—Betamethasone—rheumatoid arthritis	0.000337	0.000725	CcSEcCtD
Maprotiline—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000334	0.000718	CcSEcCtD
Maprotiline—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000333	0.000716	CcSEcCtD
Maprotiline—Hepatitis—Methotrexate—rheumatoid arthritis	0.000332	0.000714	CcSEcCtD
Maprotiline—Nausea—Leflunomide—rheumatoid arthritis	0.000329	0.000707	CcSEcCtD
Maprotiline—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000328	0.000705	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000328	0.000705	CcSEcCtD
Maprotiline—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000327	0.000704	CcSEcCtD
Maprotiline—Vision blurred—Prednisone—rheumatoid arthritis	0.000326	0.000701	CcSEcCtD
Maprotiline—Urethral disorder—Methotrexate—rheumatoid arthritis	0.000326	0.0007	CcSEcCtD
Maprotiline—Oedema—Dexamethasone—rheumatoid arthritis	0.000324	0.000697	CcSEcCtD
Maprotiline—Oedema—Betamethasone—rheumatoid arthritis	0.000324	0.000697	CcSEcCtD
Maprotiline—Insomnia—Triamcinolone—rheumatoid arthritis	0.000323	0.000695	CcSEcCtD
Maprotiline—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000323	0.000693	CcSEcCtD
Maprotiline—Infection—Betamethasone—rheumatoid arthritis	0.000322	0.000693	CcSEcCtD
Maprotiline—Infection—Dexamethasone—rheumatoid arthritis	0.000322	0.000693	CcSEcCtD
Maprotiline—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000321	0.00069	CcSEcCtD
Maprotiline—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.00032	0.000689	CcSEcCtD
Maprotiline—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.00032	0.000688	CcSEcCtD
Maprotiline—Shock—Dexamethasone—rheumatoid arthritis	0.000319	0.000686	CcSEcCtD
Maprotiline—Shock—Betamethasone—rheumatoid arthritis	0.000319	0.000686	CcSEcCtD
Maprotiline—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000318	0.000684	CcSEcCtD
Maprotiline—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000318	0.000684	CcSEcCtD
Maprotiline—Agitation—Prednisone—rheumatoid arthritis	0.000318	0.000684	CcSEcCtD
Maprotiline—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000318	0.000683	CcSEcCtD
Maprotiline—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000318	0.000683	CcSEcCtD
Maprotiline—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000317	0.00068	CcSEcCtD
Maprotiline—Tachycardia—Betamethasone—rheumatoid arthritis	0.000317	0.00068	CcSEcCtD
Maprotiline—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000315	0.000676	CcSEcCtD
Maprotiline—Erythema multiforme—Methotrexate—rheumatoid arthritis	0.000314	0.000675	CcSEcCtD
Maprotiline—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.000314	0.000675	CcSEcCtD
Maprotiline—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000314	0.000674	CcSEcCtD
Maprotiline—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000314	0.000674	CcSEcCtD
Maprotiline—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000313	0.000673	CcSEcCtD
Maprotiline—Eye disorder—Methotrexate—rheumatoid arthritis	0.00031	0.000668	CcSEcCtD
Maprotiline—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.00031	0.000667	CcSEcCtD
Maprotiline—Syncope—Prednisone—rheumatoid arthritis	0.00031	0.000667	CcSEcCtD
Maprotiline—Tinnitus—Methotrexate—rheumatoid arthritis	0.00031	0.000666	CcSEcCtD
Maprotiline—Urticaria—Prednisolone—rheumatoid arthritis	0.000309	0.000664	CcSEcCtD
Maprotiline—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000308	0.000663	CcSEcCtD
Maprotiline—Fatigue—Triamcinolone—rheumatoid arthritis	0.000308	0.000663	CcSEcCtD
Maprotiline—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000307	0.000661	CcSEcCtD
Maprotiline—Asthenia—Cyclosporine—rheumatoid arthritis	0.000306	0.000659	CcSEcCtD
Maprotiline—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000304	0.000654	CcSEcCtD
Maprotiline—Hypotension—Dexamethasone—rheumatoid arthritis	0.000303	0.000652	CcSEcCtD
Maprotiline—Hypotension—Betamethasone—rheumatoid arthritis	0.000303	0.000652	CcSEcCtD
Maprotiline—Pruritus—Cyclosporine—rheumatoid arthritis	0.000302	0.00065	CcSEcCtD
Maprotiline—Urticaria—Hydrocortisone—rheumatoid arthritis	0.000302	0.000648	CcSEcCtD
Maprotiline—Angiopathy—Methotrexate—rheumatoid arthritis	0.000301	0.000648	CcSEcCtD
Maprotiline—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.0003	0.000645	CcSEcCtD
Maprotiline—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.0003	0.000645	CcSEcCtD
Maprotiline—Convulsion—Prednisone—rheumatoid arthritis	0.0003	0.000645	CcSEcCtD
Maprotiline—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.000299	0.000644	CcSEcCtD
Maprotiline—Hypertension—Prednisone—rheumatoid arthritis	0.000299	0.000642	CcSEcCtD
Maprotiline—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000295	0.000633	CcSEcCtD
Maprotiline—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000294	0.000632	CcSEcCtD
Maprotiline—Anxiety—Prednisone—rheumatoid arthritis	0.000294	0.000631	CcSEcCtD
Maprotiline—Alopecia—Methotrexate—rheumatoid arthritis	0.000294	0.000631	CcSEcCtD
Maprotiline—Insomnia—Dexamethasone—rheumatoid arthritis	0.000293	0.000631	CcSEcCtD
Maprotiline—Insomnia—Betamethasone—rheumatoid arthritis	0.000293	0.000631	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000293	0.000629	CcSEcCtD
Maprotiline—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000292	0.000628	CcSEcCtD
Maprotiline—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000292	0.000627	CcSEcCtD
Maprotiline—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000291	0.000626	CcSEcCtD
Maprotiline—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000291	0.000626	CcSEcCtD
Maprotiline—Malnutrition—Methotrexate—rheumatoid arthritis	0.000289	0.000622	CcSEcCtD
Maprotiline—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000285	0.000614	CcSEcCtD
Maprotiline—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000285	0.000614	CcSEcCtD
Maprotiline—Urticaria—Triamcinolone—rheumatoid arthritis	0.000284	0.00061	CcSEcCtD
Maprotiline—Urticaria—Methylprednisolone—rheumatoid arthritis	0.000283	0.000609	CcSEcCtD
Maprotiline—Dysgeusia—Methotrexate—rheumatoid arthritis	0.000283	0.000609	CcSEcCtD
Maprotiline—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000283	0.000607	CcSEcCtD
Maprotiline—Dizziness—Cyclosporine—rheumatoid arthritis	0.000282	0.000607	CcSEcCtD
Maprotiline—Oedema—Prednisone—rheumatoid arthritis	0.000282	0.000607	CcSEcCtD
Maprotiline—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000282	0.000606	CcSEcCtD
Maprotiline—Infection—Prednisone—rheumatoid arthritis	0.000281	0.000603	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.00028	0.000602	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.00028	0.000602	CcSEcCtD
Maprotiline—Fatigue—Dexamethasone—rheumatoid arthritis	0.00028	0.000601	CcSEcCtD
Maprotiline—Fatigue—Betamethasone—rheumatoid arthritis	0.00028	0.000601	CcSEcCtD
Maprotiline—Shock—Prednisone—rheumatoid arthritis	0.000278	0.000597	CcSEcCtD
Maprotiline—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000277	0.000595	CcSEcCtD
Maprotiline—Tachycardia—Prednisone—rheumatoid arthritis	0.000276	0.000593	CcSEcCtD
Maprotiline—Skin disorder—Prednisone—rheumatoid arthritis	0.000274	0.00059	CcSEcCtD
Maprotiline—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000273	0.000587	CcSEcCtD
Maprotiline—Vision blurred—Methotrexate—rheumatoid arthritis	0.000273	0.000586	CcSEcCtD
Maprotiline—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000272	0.000586	CcSEcCtD
Maprotiline—Vomiting—Cyclosporine—rheumatoid arthritis	0.000272	0.000584	CcSEcCtD
Maprotiline—Rash—Cyclosporine—rheumatoid arthritis	0.000269	0.000579	CcSEcCtD
Maprotiline—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000269	0.000578	CcSEcCtD
Maprotiline—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000269	0.000577	CcSEcCtD
Maprotiline—Headache—Cyclosporine—rheumatoid arthritis	0.000268	0.000575	CcSEcCtD
Maprotiline—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000267	0.000575	CcSEcCtD
Maprotiline—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000267	0.000575	CcSEcCtD
Maprotiline—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000265	0.00057	CcSEcCtD
Maprotiline—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000265	0.00057	CcSEcCtD
Maprotiline—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.00026	0.000558	CcSEcCtD
Maprotiline—Leukopenia—Methotrexate—rheumatoid arthritis	0.000259	0.000557	CcSEcCtD
Maprotiline—Urticaria—Betamethasone—rheumatoid arthritis	0.000258	0.000554	CcSEcCtD
Maprotiline—Urticaria—Dexamethasone—rheumatoid arthritis	0.000258	0.000554	CcSEcCtD
Maprotiline—Dizziness—Prednisolone—rheumatoid arthritis	0.000257	0.000553	CcSEcCtD
Maprotiline—Asthenia—Triamcinolone—rheumatoid arthritis	0.000256	0.000551	CcSEcCtD
Maprotiline—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000256	0.000551	CcSEcCtD
Maprotiline—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000256	0.000551	CcSEcCtD
Maprotiline—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000256	0.000551	CcSEcCtD
Maprotiline—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000256	0.000551	CcSEcCtD
Maprotiline—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000256	0.00055	CcSEcCtD
Maprotiline—Insomnia—Prednisone—rheumatoid arthritis	0.000255	0.000549	CcSEcCtD
Maprotiline—Nausea—Cyclosporine—rheumatoid arthritis	0.000254	0.000545	CcSEcCtD
Maprotiline—Paraesthesia—Prednisone—rheumatoid arthritis	0.000254	0.000545	CcSEcCtD
Maprotiline—Pruritus—Triamcinolone—rheumatoid arthritis	0.000253	0.000544	CcSEcCtD
Maprotiline—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000252	0.000542	CcSEcCtD
Maprotiline—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000251	0.00054	CcSEcCtD
Maprotiline—Convulsion—Methotrexate—rheumatoid arthritis	0.000251	0.000539	CcSEcCtD
Maprotiline—Dyspepsia—Prednisone—rheumatoid arthritis	0.000249	0.000534	CcSEcCtD
Maprotiline—Rash—Prednisolone—rheumatoid arthritis	0.000245	0.000527	CcSEcCtD
Maprotiline—Dermatitis—Prednisolone—rheumatoid arthritis	0.000245	0.000526	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000245	0.000526	CcSEcCtD
Maprotiline—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000244	0.000525	CcSEcCtD
Maprotiline—Fatigue—Prednisone—rheumatoid arthritis	0.000243	0.000524	CcSEcCtD
Maprotiline—Headache—Prednisolone—rheumatoid arthritis	0.000243	0.000523	CcSEcCtD
Maprotiline—Constipation—Prednisone—rheumatoid arthritis	0.000242	0.000519	CcSEcCtD
Maprotiline—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000241	0.000519	CcSEcCtD
Maprotiline—Rash—Hydrocortisone—rheumatoid arthritis	0.000239	0.000515	CcSEcCtD
Maprotiline—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000239	0.000514	CcSEcCtD
Maprotiline—Confusional state—Methotrexate—rheumatoid arthritis	0.000238	0.000512	CcSEcCtD
Maprotiline—Headache—Hydrocortisone—rheumatoid arthritis	0.000238	0.000511	CcSEcCtD
Maprotiline—Dizziness—Triamcinolone—rheumatoid arthritis	0.000236	0.000508	CcSEcCtD
Maprotiline—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000236	0.000507	CcSEcCtD
Maprotiline—Infection—Methotrexate—rheumatoid arthritis	0.000234	0.000504	CcSEcCtD
Maprotiline—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000233	0.0005	CcSEcCtD
Maprotiline—Asthenia—Betamethasone—rheumatoid arthritis	0.000233	0.0005	CcSEcCtD
Maprotiline—Asthenia—Dexamethasone—rheumatoid arthritis	0.000233	0.0005	CcSEcCtD
Maprotiline—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000231	0.000498	CcSEcCtD
Maprotiline—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000231	0.000497	CcSEcCtD
Maprotiline—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000231	0.000497	CcSEcCtD
Maprotiline—Nausea—Prednisolone—rheumatoid arthritis	0.000231	0.000496	CcSEcCtD
Maprotiline—Pruritus—Dexamethasone—rheumatoid arthritis	0.000229	0.000493	CcSEcCtD
Maprotiline—Pruritus—Betamethasone—rheumatoid arthritis	0.000229	0.000493	CcSEcCtD
Maprotiline—Skin disorder—Methotrexate—rheumatoid arthritis	0.000229	0.000493	CcSEcCtD
Maprotiline—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.000228	0.000491	CcSEcCtD
Maprotiline—Vomiting—Triamcinolone—rheumatoid arthritis	0.000227	0.000489	CcSEcCtD
Maprotiline—Vomiting—Methylprednisolone—rheumatoid arthritis	0.000227	0.000487	CcSEcCtD
Maprotiline—Nausea—Hydrocortisone—rheumatoid arthritis	0.000225	0.000485	CcSEcCtD
Maprotiline—Rash—Triamcinolone—rheumatoid arthritis	0.000225	0.000485	CcSEcCtD
Maprotiline—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000225	0.000484	CcSEcCtD
Maprotiline—Rash—Methylprednisolone—rheumatoid arthritis	0.000225	0.000483	CcSEcCtD
Maprotiline—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000225	0.000483	CcSEcCtD
Maprotiline—Urticaria—Prednisone—rheumatoid arthritis	0.000224	0.000482	CcSEcCtD
Maprotiline—Headache—Triamcinolone—rheumatoid arthritis	0.000224	0.000481	CcSEcCtD
Maprotiline—Headache—Methylprednisolone—rheumatoid arthritis	0.000223	0.00048	CcSEcCtD
Maprotiline—Abdominal pain—Prednisone—rheumatoid arthritis	0.000223	0.00048	CcSEcCtD
Maprotiline—Body temperature increased—Prednisone—rheumatoid arthritis	0.000223	0.00048	CcSEcCtD
Maprotiline—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000222	0.000477	CcSEcCtD
Maprotiline—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000222	0.000477	CcSEcCtD
Maprotiline—Hypotension—Methotrexate—rheumatoid arthritis	0.000221	0.000474	CcSEcCtD
Maprotiline—Dizziness—Betamethasone—rheumatoid arthritis	0.000214	0.000461	CcSEcCtD
Maprotiline—Dizziness—Dexamethasone—rheumatoid arthritis	0.000214	0.000461	CcSEcCtD
Maprotiline—Insomnia—Methotrexate—rheumatoid arthritis	0.000213	0.000459	CcSEcCtD
Maprotiline—Nausea—Triamcinolone—rheumatoid arthritis	0.000212	0.000456	CcSEcCtD
Maprotiline—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000212	0.000456	CcSEcCtD
Maprotiline—Nausea—Methylprednisolone—rheumatoid arthritis	0.000212	0.000455	CcSEcCtD
Maprotiline—Somnolence—Methotrexate—rheumatoid arthritis	0.00021	0.000451	CcSEcCtD
Maprotiline—Dyspepsia—Methotrexate—rheumatoid arthritis	0.000208	0.000447	CcSEcCtD
Maprotiline—Vomiting—Betamethasone—rheumatoid arthritis	0.000206	0.000443	CcSEcCtD
Maprotiline—Vomiting—Dexamethasone—rheumatoid arthritis	0.000206	0.000443	CcSEcCtD
Maprotiline—Rash—Betamethasone—rheumatoid arthritis	0.000204	0.00044	CcSEcCtD
Maprotiline—Rash—Dexamethasone—rheumatoid arthritis	0.000204	0.00044	CcSEcCtD
Maprotiline—Dermatitis—Betamethasone—rheumatoid arthritis	0.000204	0.000439	CcSEcCtD
Maprotiline—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000204	0.000439	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000204	0.000438	CcSEcCtD
Maprotiline—Fatigue—Methotrexate—rheumatoid arthritis	0.000203	0.000438	CcSEcCtD
Maprotiline—Headache—Dexamethasone—rheumatoid arthritis	0.000203	0.000437	CcSEcCtD
Maprotiline—Headache—Betamethasone—rheumatoid arthritis	0.000203	0.000437	CcSEcCtD
Maprotiline—Asthenia—Prednisone—rheumatoid arthritis	0.000203	0.000436	CcSEcCtD
Maprotiline—Pruritus—Prednisone—rheumatoid arthritis	0.0002	0.00043	CcSEcCtD
Maprotiline—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000195	0.000418	CcSEcCtD
Maprotiline—Diarrhoea—Prednisone—rheumatoid arthritis	0.000193	0.000415	CcSEcCtD
Maprotiline—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000193	0.000415	CcSEcCtD
Maprotiline—Nausea—Dexamethasone—rheumatoid arthritis	0.000193	0.000414	CcSEcCtD
Maprotiline—Nausea—Betamethasone—rheumatoid arthritis	0.000193	0.000414	CcSEcCtD
Maprotiline—Urticaria—Methotrexate—rheumatoid arthritis	0.000188	0.000403	CcSEcCtD
Maprotiline—Dizziness—Prednisone—rheumatoid arthritis	0.000187	0.000402	CcSEcCtD
Maprotiline—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000187	0.000401	CcSEcCtD
Maprotiline—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000187	0.000401	CcSEcCtD
Maprotiline—Vomiting—Prednisone—rheumatoid arthritis	0.00018	0.000386	CcSEcCtD
Maprotiline—Rash—Prednisone—rheumatoid arthritis	0.000178	0.000383	CcSEcCtD
Maprotiline—Dermatitis—Prednisone—rheumatoid arthritis	0.000178	0.000382	CcSEcCtD
Maprotiline—Headache—Prednisone—rheumatoid arthritis	0.000177	0.00038	CcSEcCtD
Maprotiline—Asthenia—Methotrexate—rheumatoid arthritis	0.000169	0.000364	CcSEcCtD
Maprotiline—Nausea—Prednisone—rheumatoid arthritis	0.000168	0.000361	CcSEcCtD
Maprotiline—Pruritus—Methotrexate—rheumatoid arthritis	0.000167	0.000359	CcSEcCtD
Maprotiline—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000161	0.000347	CcSEcCtD
Maprotiline—Dizziness—Methotrexate—rheumatoid arthritis	0.000156	0.000336	CcSEcCtD
Maprotiline—Vomiting—Methotrexate—rheumatoid arthritis	0.00015	0.000323	CcSEcCtD
Maprotiline—Rash—Methotrexate—rheumatoid arthritis	0.000149	0.00032	CcSEcCtD
Maprotiline—Dermatitis—Methotrexate—rheumatoid arthritis	0.000149	0.00032	CcSEcCtD
Maprotiline—Headache—Methotrexate—rheumatoid arthritis	0.000148	0.000318	CcSEcCtD
Maprotiline—Nortriptyline—ALB—rheumatoid arthritis	0.000144	0.12	CrCbGaD
Maprotiline—Nausea—Methotrexate—rheumatoid arthritis	0.00014	0.000301	CcSEcCtD
Maprotiline—HRH1—Signaling Pathways—CCL5—rheumatoid arthritis	1.84e-05	0.000105	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	1.84e-05	0.000105	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—POMC—rheumatoid arthritis	1.84e-05	0.000105	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCL5—rheumatoid arthritis	1.84e-05	0.000105	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCL5—rheumatoid arthritis	1.83e-05	0.000104	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—IL2—rheumatoid arthritis	1.82e-05	0.000104	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CSF2—rheumatoid arthritis	1.82e-05	0.000104	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CSF2—rheumatoid arthritis	1.81e-05	0.000103	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCL5—rheumatoid arthritis	1.81e-05	0.000103	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CSF2—rheumatoid arthritis	1.81e-05	0.000103	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TYK2—rheumatoid arthritis	1.8e-05	0.000103	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CSF2—rheumatoid arthritis	1.8e-05	0.000103	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CCL2—rheumatoid arthritis	1.8e-05	0.000102	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—IL2—rheumatoid arthritis	1.79e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6R—rheumatoid arthritis	1.79e-05	0.000102	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—IL2—rheumatoid arthritis	1.79e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CSF2—rheumatoid arthritis	1.79e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—IL2—rheumatoid arthritis	1.78e-05	0.000102	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—IL2—rheumatoid arthritis	1.78e-05	0.000101	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NOS3—rheumatoid arthritis	1.77e-05	0.000101	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—IL2—rheumatoid arthritis	1.76e-05	0.0001	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.75e-05	9.99e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—LEP—rheumatoid arthritis	1.74e-05	9.93e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SPP1—rheumatoid arthritis	1.74e-05	9.9e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.73e-05	9.86e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SPP1—rheumatoid arthritis	1.71e-05	9.75e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SPP1—rheumatoid arthritis	1.71e-05	9.72e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TYK2—rheumatoid arthritis	1.7e-05	9.71e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.7e-05	9.7e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SPP1—rheumatoid arthritis	1.7e-05	9.69e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.7e-05	9.68e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SPP1—rheumatoid arthritis	1.7e-05	9.66e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.69e-05	9.65e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCR5—rheumatoid arthritis	1.69e-05	9.63e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.69e-05	9.62e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SPP1—rheumatoid arthritis	1.68e-05	9.57e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NOS3—rheumatoid arthritis	1.67e-05	9.53e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.67e-05	9.53e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL2RA—rheumatoid arthritis	1.67e-05	9.5e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCR5—rheumatoid arthritis	1.66e-05	9.48e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCR5—rheumatoid arthritis	1.66e-05	9.46e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCR5—rheumatoid arthritis	1.65e-05	9.43e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL2—rheumatoid arthritis	1.65e-05	9.42e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—C3—rheumatoid arthritis	1.65e-05	9.42e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCR5—rheumatoid arthritis	1.65e-05	9.4e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—FN1—rheumatoid arthritis	1.64e-05	9.37e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL2RA—rheumatoid arthritis	1.64e-05	9.34e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6ST—rheumatoid arthritis	1.64e-05	9.33e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL2RA—rheumatoid arthritis	1.64e-05	9.32e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCR5—rheumatoid arthritis	1.63e-05	9.31e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TYK2—rheumatoid arthritis	1.63e-05	9.3e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL2RA—rheumatoid arthritis	1.63e-05	9.29e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL2—rheumatoid arthritis	1.63e-05	9.27e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—C3—rheumatoid arthritis	1.63e-05	9.26e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL2RA—rheumatoid arthritis	1.63e-05	9.26e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	1.63e-05	9.26e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL2—rheumatoid arthritis	1.62e-05	9.25e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—C3—rheumatoid arthritis	1.62e-05	9.24e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL2—rheumatoid arthritis	1.62e-05	9.22e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—C3—rheumatoid arthritis	1.62e-05	9.21e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL2—rheumatoid arthritis	1.61e-05	9.19e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—C3—rheumatoid arthritis	1.61e-05	9.19e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL2RA—rheumatoid arthritis	1.61e-05	9.17e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NOS3—rheumatoid arthritis	1.6e-05	9.13e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.6e-05	9.11e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL2—rheumatoid arthritis	1.6e-05	9.1e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—C3—rheumatoid arthritis	1.6e-05	9.1e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CD80—rheumatoid arthritis	1.58e-05	8.98e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CXCL8—rheumatoid arthritis	1.57e-05	8.95e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—POMC—rheumatoid arthritis	1.54e-05	8.79e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—LEP—rheumatoid arthritis	1.54e-05	8.77e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—LEP—rheumatoid arthritis	1.51e-05	8.62e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—LEP—rheumatoid arthritis	1.51e-05	8.61e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—LEP—rheumatoid arthritis	1.51e-05	8.58e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL2—rheumatoid arthritis	1.5e-05	8.56e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—LEP—rheumatoid arthritis	1.5e-05	8.55e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—POMC—rheumatoid arthritis	1.5e-05	8.53e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—IL6—rheumatoid arthritis	1.49e-05	8.51e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—LEP—rheumatoid arthritis	1.49e-05	8.47e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CXCL8—rheumatoid arthritis	1.48e-05	8.45e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CAT—rheumatoid arthritis	1.47e-05	8.35e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCL2—rheumatoid arthritis	1.46e-05	8.35e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6R—rheumatoid arthritis	1.46e-05	8.32e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—FN1—rheumatoid arthritis	1.45e-05	8.27e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6ST—rheumatoid arthritis	1.44e-05	8.23e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—FN1—rheumatoid arthritis	1.43e-05	8.13e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—FN1—rheumatoid arthritis	1.42e-05	8.12e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.42e-05	8.1e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MMP9—rheumatoid arthritis	1.42e-05	8.1e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CXCL8—rheumatoid arthritis	1.42e-05	8.1e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—FN1—rheumatoid arthritis	1.42e-05	8.09e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6ST—rheumatoid arthritis	1.42e-05	8.08e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL2—rheumatoid arthritis	1.42e-05	8.08e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—FN1—rheumatoid arthritis	1.42e-05	8.06e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6ST—rheumatoid arthritis	1.41e-05	8.06e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL6—rheumatoid arthritis	1.41e-05	8.04e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6ST—rheumatoid arthritis	1.41e-05	8.03e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—NFKB1—rheumatoid arthritis	1.41e-05	8.01e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ALB—rheumatoid arthritis	1.41e-05	8.01e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—FN1—rheumatoid arthritis	1.4e-05	7.99e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.4e-05	7.97e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6ST—rheumatoid arthritis	1.4e-05	7.95e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CD80—rheumatoid arthritis	1.39e-05	7.92e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MAPK8—rheumatoid arthritis	1.38e-05	7.88e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CAT—rheumatoid arthritis	1.38e-05	7.87e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CD80—rheumatoid arthritis	1.37e-05	7.8e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CD80—rheumatoid arthritis	1.37e-05	7.78e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CD80—rheumatoid arthritis	1.36e-05	7.76e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL2—rheumatoid arthritis	1.36e-05	7.74e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CD80—rheumatoid arthritis	1.36e-05	7.73e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL6—rheumatoid arthritis	1.35e-05	7.7e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—NOS3—rheumatoid arthritis	1.34e-05	7.66e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CD80—rheumatoid arthritis	1.34e-05	7.66e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MMP9—rheumatoid arthritis	1.34e-05	7.65e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TYK2—rheumatoid arthritis	1.33e-05	7.58e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NFKB1—rheumatoid arthritis	1.33e-05	7.57e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—POMC—rheumatoid arthritis	1.32e-05	7.53e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NOS3—rheumatoid arthritis	1.31e-05	7.44e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MAPK8—rheumatoid arthritis	1.31e-05	7.44e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—POMC—rheumatoid arthritis	1.3e-05	7.41e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—POMC—rheumatoid arthritis	1.3e-05	7.39e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—POMC—rheumatoid arthritis	1.29e-05	7.37e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCL2—rheumatoid arthritis	1.29e-05	7.37e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—POMC—rheumatoid arthritis	1.29e-05	7.35e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6R—rheumatoid arthritis	1.29e-05	7.35e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MMP9—rheumatoid arthritis	1.29e-05	7.32e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—POMC—rheumatoid arthritis	1.28e-05	7.27e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—VEGFA—rheumatoid arthritis	1.28e-05	7.27e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCL2—rheumatoid arthritis	1.27e-05	7.25e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NFKB1—rheumatoid arthritis	1.27e-05	7.25e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCL2—rheumatoid arthritis	1.27e-05	7.23e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6R—rheumatoid arthritis	1.27e-05	7.23e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6R—rheumatoid arthritis	1.27e-05	7.21e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCL2—rheumatoid arthritis	1.27e-05	7.21e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6R—rheumatoid arthritis	1.26e-05	7.19e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCL2—rheumatoid arthritis	1.26e-05	7.19e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6R—rheumatoid arthritis	1.26e-05	7.17e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MAPK8—rheumatoid arthritis	1.25e-05	7.12e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCL2—rheumatoid arthritis	1.25e-05	7.12e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6R—rheumatoid arthritis	1.25e-05	7.1e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PTGS2—rheumatoid arthritis	1.23e-05	7.01e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	1.22e-05	6.97e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—VEGFA—rheumatoid arthritis	1.2e-05	6.87e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TYK2—rheumatoid arthritis	1.17e-05	6.69e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TGFB1—rheumatoid arthritis	1.17e-05	6.67e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CAT—rheumatoid arthritis	1.17e-05	6.67e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CXCL8—rheumatoid arthritis	1.16e-05	6.6e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TYK2—rheumatoid arthritis	1.16e-05	6.58e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—VEGFA—rheumatoid arthritis	1.15e-05	6.58e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TYK2—rheumatoid arthritis	1.15e-05	6.57e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	1.15e-05	6.57e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NOS3—rheumatoid arthritis	1.15e-05	6.57e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TYK2—rheumatoid arthritis	1.15e-05	6.55e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TYK2—rheumatoid arthritis	1.15e-05	6.53e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TYK2—rheumatoid arthritis	1.13e-05	6.46e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NOS3—rheumatoid arthritis	1.13e-05	6.46e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NOS3—rheumatoid arthritis	1.13e-05	6.45e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NOS3—rheumatoid arthritis	1.13e-05	6.43e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NOS3—rheumatoid arthritis	1.12e-05	6.41e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NOS3—rheumatoid arthritis	1.11e-05	6.34e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL2—rheumatoid arthritis	1.11e-05	6.31e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TGFB1—rheumatoid arthritis	1.11e-05	6.3e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6—rheumatoid arthritis	1.1e-05	6.28e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TGFB1—rheumatoid arthritis	1.06e-05	6.04e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MMP9—rheumatoid arthritis	1.05e-05	5.97e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NFKB1—rheumatoid arthritis	1.04e-05	5.91e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CXCL8—rheumatoid arthritis	1.02e-05	5.82e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MAPK8—rheumatoid arthritis	1.02e-05	5.81e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.01e-05	5.73e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CXCL8—rheumatoid arthritis	1e-05	5.72e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CXCL8—rheumatoid arthritis	1e-05	5.7e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CXCL8—rheumatoid arthritis	9.97e-06	5.68e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CXCL8—rheumatoid arthritis	9.88e-06	5.63e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—POMC—rheumatoid arthritis	9.78e-06	5.57e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL2—rheumatoid arthritis	9.77e-06	5.57e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	9.76e-06	5.56e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6—rheumatoid arthritis	9.72e-06	5.54e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TP53—rheumatoid arthritis	9.64e-06	5.49e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL2—rheumatoid arthritis	9.61e-06	5.48e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL2—rheumatoid arthritis	9.59e-06	5.47e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6—rheumatoid arthritis	9.56e-06	5.45e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL2—rheumatoid arthritis	9.56e-06	5.45e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6—rheumatoid arthritis	9.54e-06	5.44e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL2—rheumatoid arthritis	9.53e-06	5.43e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6—rheumatoid arthritis	9.51e-06	5.42e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6—rheumatoid arthritis	9.48e-06	5.4e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL2—rheumatoid arthritis	9.44e-06	5.38e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—VEGFA—rheumatoid arthritis	9.41e-06	5.36e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6—rheumatoid arthritis	9.39e-06	5.35e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MMP9—rheumatoid arthritis	9.25e-06	5.27e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—POMC—rheumatoid arthritis	9.22e-06	5.25e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NFKB1—rheumatoid arthritis	9.15e-06	5.21e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TP53—rheumatoid arthritis	9.1e-06	5.19e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MMP9—rheumatoid arthritis	9.1e-06	5.18e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MMP9—rheumatoid arthritis	9.08e-06	5.17e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MMP9—rheumatoid arthritis	9.05e-06	5.16e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MMP9—rheumatoid arthritis	9.02e-06	5.14e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NFKB1—rheumatoid arthritis	9e-06	5.13e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MAPK8—rheumatoid arthritis	8.99e-06	5.12e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NFKB1—rheumatoid arthritis	8.98e-06	5.12e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NFKB1—rheumatoid arthritis	8.95e-06	5.1e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MMP9—rheumatoid arthritis	8.93e-06	5.09e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NFKB1—rheumatoid arthritis	8.92e-06	5.09e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ALB—rheumatoid arthritis	8.92e-06	5.08e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MAPK8—rheumatoid arthritis	8.85e-06	5.04e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NFKB1—rheumatoid arthritis	8.84e-06	5.04e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MAPK8—rheumatoid arthritis	8.83e-06	5.03e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6—rheumatoid arthritis	8.82e-06	5.03e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MAPK8—rheumatoid arthritis	8.8e-06	5.01e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MAPK8—rheumatoid arthritis	8.77e-06	5e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TP53—rheumatoid arthritis	8.72e-06	4.97e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MAPK8—rheumatoid arthritis	8.69e-06	4.95e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TGFB1—rheumatoid arthritis	8.63e-06	4.92e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—NOS3—rheumatoid arthritis	8.53e-06	4.86e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ALB—rheumatoid arthritis	8.4e-06	4.79e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6—rheumatoid arthritis	8.33e-06	4.75e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VEGFA—rheumatoid arthritis	8.3e-06	4.73e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VEGFA—rheumatoid arthritis	8.17e-06	4.65e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VEGFA—rheumatoid arthritis	8.15e-06	4.64e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VEGFA—rheumatoid arthritis	8.12e-06	4.63e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VEGFA—rheumatoid arthritis	8.1e-06	4.62e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	8.04e-06	4.58e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VEGFA—rheumatoid arthritis	8.02e-06	4.57e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6—rheumatoid arthritis	7.98e-06	4.55e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—POMC—rheumatoid arthritis	7.81e-06	4.45e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	7.8e-06	4.45e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TGFB1—rheumatoid arthritis	7.62e-06	4.34e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TGFB1—rheumatoid arthritis	7.5e-06	4.27e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TGFB1—rheumatoid arthritis	7.48e-06	4.26e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TGFB1—rheumatoid arthritis	7.46e-06	4.25e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TGFB1—rheumatoid arthritis	7.43e-06	4.24e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TGFB1—rheumatoid arthritis	7.36e-06	4.19e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	7.35e-06	4.19e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ALB—rheumatoid arthritis	7.12e-06	4.06e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TP53—rheumatoid arthritis	7.11e-06	4.05e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	6.81e-06	3.88e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6—rheumatoid arthritis	6.51e-06	3.71e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TP53—rheumatoid arthritis	6.27e-06	3.57e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	6.23e-06	3.55e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TP53—rheumatoid arthritis	6.17e-06	3.52e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TP53—rheumatoid arthritis	6.16e-06	3.51e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TP53—rheumatoid arthritis	6.14e-06	3.5e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TP53—rheumatoid arthritis	6.12e-06	3.49e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TP53—rheumatoid arthritis	6.06e-06	3.45e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6—rheumatoid arthritis	5.74e-06	3.27e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6—rheumatoid arthritis	5.65e-06	3.22e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6—rheumatoid arthritis	5.64e-06	3.21e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6—rheumatoid arthritis	5.62e-06	3.2e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6—rheumatoid arthritis	5.6e-06	3.19e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6—rheumatoid arthritis	5.55e-06	3.16e-05	CbGpPWpGaD
